N-(4-Fluorophenyl)-N'-(4-hydroxyphenyl)cyclopropane-1,1-dicarboxamide
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

849217-60-3N-(4-Fluorophenyl)-N'-(4-hydroxyphenyl)cyclopropane-1,1-dicarboxamide

● In Stock

Catalogue No.:VE0010596
CAS No.:849217-60-3
Mol. Formula:C17H15FN2O3
Mol. Weight:314.31 g/mol

Additional information on CAS 849217-60-3

Parent drug

Cabozantinib

IUPAC Name

N-(4-Fluorophenyl)-n’-(4-hydroxyphenyl)cyclopropane-1,1-dicarboxamide

Pharmacopeial Synonyms

N/A

Synonyms

Cabozantinib Hydroxy Impurity; Cabozantinib Impurity 7

Smiles

O=C(C1(C(NC2=CC=C(O)C=C2)=O)CC1)NC3=CC=C(F)C=C3

InChI

InChI=1S/C17H15FN2O3/c18-11-1-3-12(4-2-11)19-15(22)17(9-10-17)16(23)20-13-5-7-14(21)8-6-13/h1-8,21H,9-10H2,(H,19,22)(H,20,23)

Description

N-(4-Fluorophenyl)-N’-(4-hydroxyphenyl)cyclopropane-1,1-dicarboxamide is a well-characterized reference material that meets stringent regulatory standards set by USP, EMA, JP, and BP. It plays a key role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Cabozantinib.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url